GelStat Corporation (GSAC)

[greenlife]

Reported revenue of $14,038 up 261% versus $3,880 over the same period in 2013 and up 136% from $5,942 in the 1st quarter ended 3/31/14. The revenue growth was attributable to increasing sales of GelStat Migraine primarily driven by small advertising tests designed to drive new customer acquisitions. While the revenue numbers themselves are insignificant, the trends and validation of marketing efforts are very meaningful.

Yes they are.. We are on the right track ... Slow and steady we will build this company and reward us shareholders..